Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens

Clinical and Vaccine Immunology

Volumn 17, Issue 11, 2010, Pages 1695-1707

  Priest, Jeffrey W ^a   Moss, Delynn M ^a   Visvesvara, Govinda S ^a   Jones, Cara C ^a,b   Li, Anna ^d   Isaac Renton, Judith L ^c,d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIGEN; RECOMBINANT ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; EPIDEMIC; EPITOPE MAPPING; GIARDIA LAMBLIA; GIARDIASIS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MOUSE; MULTIPLEX BEAD ASSAY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BRITISH COLUMBIA; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DISEASE OUTBREAKS; GIARDIA LAMBLIA; GIARDIASIS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; PARASITOLOGY; SENSITIVITY AND SPECIFICITY;

EID: 78449237490     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00160-10     Document Type: Article

References (94)

1. Abaza, S. M., J. J. Sullivan, and G. S. Visvesvara. 1991. Isoenzyme profile of four strains of Giardia lamblia and their infectivity to jirds. Am. J. Trop. Med. Hyg. 44:63-68.
2. Adam, R. D. 2001. Biology of Giardia lamblia. Clin. Microbiol. Rev. 14:447-475.
3. Adam, R. D., A. Nigam, V. Seshadri, C. A. Martens, G. A. Farneth, H. G. Morrison, T. E. Nash, S. F. Porcella, and R. Patel. 2010. The Giradia lamblia vsp gene repertoire: characteristics, genomic organization, and evolution. BMC Genomics 11:424.
4. Adam, R. D., Y. M. Yang, and T. E. Nash. 1992. The cysteine-rich protein gene family of Giardia lamblia: loss of the CRP170 gene in an antigenic determinant. Mol. Cell. Biol. 12:1194-1201.
5. Aggarwal, A., J. W. Merritt, Jr., and T. E. Nash. 1989. Cysteine-rich variant surface proteins of Giardia lamblia. Mol. Biochem. Parasitol. 32:39-47.
6. Bern, C., Y. Ortega, W. Checkley, J. M. Roberts, A. G. Lescano, L. Cabrera, M. Verastegui, R. E. Black, C. Sterling, and R. H. Gilman. 2002. Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children. Emerg. Infect. Dis. 8:581-585.
7. Betancourt, W. Q., and J. B. Rose. 2004. Drinking water treatment processes for removal of Cryptosporidium and Giardia. Vet. Parasitol. 126:219-234.
8. Bienz, M., A. Siles-Lucas, P. Wittwer, and N. Muller. 2001. vsp gene expression by Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in vitro. Infect. Immun. 69:5278-5285.
9. Bienz, M., P. Wittwer, V. Zimmermann, and N. Muller. 2001. Molecular characterization of a predominant antigenic region of Giardia lamblia variant surface protein H7. Int. J. Parasitol. 31:827-832.
10. Birkhead, G., E. N. Janoff, R. L. Vogt, and P. D. Smith. 1989. Elevated levels of immunoglobulin A to Giardia lamblia during a waterborne outbreak of gastroenteritis. J. Clin. Microbiol. 27:1707-1710.
11. British Columbia Ministry of Health Planning. 2001. A report on the health of British Columbians. Drinking water quality in British Columbia: the public health perspective. Provincial Health Officer's annual report 2000. Ministry of Health Planning, Victoria, British Columbia.
12. Casemore, D. 2006. Towards a U.S. national estimate of the risk of endemic waterborne disease - sero-epidemiologic studies. J. Water Health 4(Suppl. 2):121-163.
13. CDC. 1998. Foodborne outbreak of cryptosporidiosis - Spokane, Washington, 1997. MMWR Morb. Mortal. Wkly. Rep. 227:565-567.
14. Chappell, C. L., P. C. Okhuysen, C. R. Sterling, and H. L. DuPont. 1996. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J. Infect. Dis. 173:232-236.
15. Craun, G. F., R. L. Calderon, and M. F. Craun. 2005. Outbreaks associated with recreational water in the United States. Int. J. Environ. Health Res. 15:243-262.
16. Crump, J. A., C. E. Mendoza, J. W. Priest, R. I. Glass, S. S. Monroe, L. A. Dauphin, W. F. Bibb, M. B. Lopez, M. Alvarez, E. D. Mintz, and S. P. Luby. 2007. Comparing serologic response against enteric pathogens with reported diarrhea to assess the impact of improved household drinking water quality. Am. J. Trop. Med. Hyg. 77:136-141.
17. Faubert, G. 2000. Immune response to Giardia duodenalis. Clin. Microbiol. Rev. 13:35-54.
18. Franzen, O., J. Jerlstrom-Hultqvist, E. Castro, E. Sherwood, J. Ankarklev, D. S. Reiner, D. Palm, J. O. Andersson, B. Andersson, and S. G. Svard. 2009. Draft genome sequencing of Giardia intestinalis assemblage B isolate GS: is human giardiasis caused by two different species. PLoS Pathog. 5:e1000560.
19. Frost, F. J., T. B. Muller, R. L. Calderon, and G. F. Craun. 2004. Analysis of serological responses to Cryptosporidium antigen among NHANES III participants. Ann. Epidemiol. 14:473-478.
20. Glaberman, S., I. M. Sulaiman, C. Bern, J. Limor, M. M. Peng, U. Morgan, R. Gilman, A. A. Lal, and L. Xiao. 2001. A multilocus genotypic analysis of Cryptosporidium meleagridis. J. Eukaryot. Microbiol. Suppl.:19S-31S.
21. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
22. Hiltpold, A., M. Frey, A. Hulsmeier, and P. Kohler. 2000. Glycosylation and palmitoylation are common modifications of Giardia variant surface proteins. Mol. Biochem. Parasitol. 109:61-65.
23. Hlavsa, M. C., J. C. Watson, and M. J. Beach. 2005. Cryptosporidiosis surveillance - United States 1999-2002. MMWR Surveill. Summ. 54:1-8.
24. Hlavsa, M. C., J. C. Watson, and M. J. Beach. 2005. Giardiasis surveillance - United States 1999-2002. MMWR Surveill. Summ. 54:9-16.
25. Hoff, J. C., E. W. Rice, and F. W. Schaefer III. 1985. Comparison of animal infectivity and excystation as measures of Giardia muris cyst inactivation by chlorine. Appl. Environ. Microbiol. 50:1115-1117.
26. Huang, D. B., and A. C. White. 2006. An updated review on Cryptosporidium and Giardia. Gastroenterol. Clin. N. Am. 35:291-314.
27. Isaac-Renton, J., J. Blatherwick, W. R. Bowie, M. Fyfe, M. Khan, A. Li, A. King, M. McLean, L. Medd, W. Moorehead, C. S. Ong, and W. Robertson. 1999. Epidemic and endemic seroprevalence of antibodies to Cryptosporidium and Giardia in residents of three communities with different drinking water supplies. Am. J. Trop. Med. Hyg. 60:578-583.
28. Isaac-Renton, J., W. Moorehead, and A. Ross. 1996. Longitudinal studies of Giardia contamination in two community drinking water supplies: cyst levels, parasite viability, and health impact. Appl. Environ. Microbiol. 62:47-54.
29. Isaac-Renton, J. L., C. Cordeiro, K. Sarafis, and H. Shahriari. 1993. Characterization of Giardia duodenalis isolates from a waterborne outbreak. J. Infect. Dis. 167:431-440.
30. Isaac-Renton, J. L., C. S. L. Ong, W. R. Bowie, P. J. Lammie, and J. W. Priest. 2003. Cryptosporidium serology in human populations. AWWA Research Foundation, Denver, CO.
31. Isaac-Renton, J. L., L. F. Lewis, C. S. L. Ong, and M. F. Nulsen. 1994. A second community outbreak of waterborne giardiasis in Canada and serologic investigation of patients. Trans. R. Soc. Trop. Med. Hyg. 88:395-399.
32. Isaac-Renton, J. L., W. A. Black, R. G. Mathis, E. M. Proctor, and C. H. Sherlock. 1986. Giardiasis in a group of travelers - attempted use of a serologic test. Can. J. Public Health 77:86-88.
33. Karanis, P., C. Kourenti, and H. Smith. 2007. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J. Water Health 5:1-38. (Pubitemid 46415958)
34. Keister, D. B. 1983. Axenic cultivation of Giardia lamblia in TYI-S-33 medium supplemented with bile. Trans. R. Soc. Trop. Med. Hyg. 77:487-488.
35. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
36. Larkin, M. A., G. Blackshields. N. P. Brown, R. Chenna, P. A. McGettigan, H. McWilliam, F. Valentin, I. M. Wallace, A. Wilm, R. Lopez, J. D. Thompson, T. J. Gibson, and D. G. Higgins. 2007. ClustalW and ClustalX version 2. Bioinformatics 23:2947-2948.
37. Lasek-Nesselquist, E., D. M. Welch, R. C. A. Thompson, R. F. Steuart, and M. L. Sogin. 2009. Genetic exchange within and between assemblages of Giardia duodenalis. J. Eukaryot. Microbiol. 56:504-518.
38. Laupland, K. B., and D. L. Church. 2005. Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region. BMC Infect. Dis. 5:72.
39. Lee, Y.-M., P. W. Johnson, J. L. Call, M. J. Arrowood, B. W. Furness, S. C. Pichette, K. W. Grady, P. Reeh, L. Mitchell, D. Bergmire-Sweat, W. R. MacKenzie, and V. C. W. Tsang. 2001. Development and application of a quantitative, specific assay for Cryptosporidium parvum oocyst detection in high-turbidity environmental water samples. Am. J. Trop. Med. Hyg. 65:1-9.
40. Lightowlers, M. W., and G. F. Mitchell. 1989. Assessment of the prevalence and titer of antibodies to a candidate schistosomiasis vaccine molecule, Sj26, in several human serum banks. Acta Trop. 46:229-238.
41. Ljungstrom, I., and B. Castor. 1992. Immune response to Giardia lamblia in a water- borne outbreak of giardiasis in Sweden. J. Med. Microbiol. 36:347-352.
42. MacKenzie, W. R., N. J. Hoxie, M. E. Proctor, M. S. Gradus, K. A. Blair, D. E. Peterson, J. J. Kazmierczak, D. G. Addiss, K. R. Fox, J. B. Rose, and J. P. Davis. 1994. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N. Engl. J. Med. 331:161-167.
43. McDonald, A. C., W. R. MacKenzie, D. G. Addiss, M. S. Gradus, G. Linke, E. Zembrowski, M. R. Hurd, M. J. Arrowood, P. J. Lammie, and J. W. Priest. 2001. Cryptosporidium parvum-specific antibody responses among children residing in Milwaukee during the 1993 waterborne outbreak. J. Infect. Dis. 183:1373-1379.
44. Meyer, E. A. 1976. Giardia lamblia: isolation and axenic culture. Exp. Parasitol. 39:101-105.
45. Mitchell, G. F. 1989. Glutathione S-transferases - potential components of anti-schistosome vaccines. Parasitol. Today 5:34-37.
46. Monis, P. T., S. M. Caccio, and R. C. A. Thompson. 2009. Variation in Giardia: towards a taxonomic revision of the genus. Trends Parasitol. 25:93-100.
47. Morrison, H. G., A. G. McArthur, F. D. Hillen, S. B. Aley, R. D. Adam, G. J. Olsen, A. A. Best, et al. 2007. Genomic minimalism in the early diverging intestinal parasite Giardia lamblia. Science 317:1921-1926.
48. Moss, D. M., C. L. Chappell, P. C. Okhuysen, H. L. DuPont, M. J. Arrowood, A. W. Hightower, and P. J. Lammie. 1998. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J. Infect. Dis. 178:827-833.
49. Moss, D. M., G. S. Visvesvara, H. M. Mathews, and D. A. Ware. 1992. Isoenzyme comparison of axenic Giardia lamblia strains. J. Protozool. 39: 559-564.
50. Moss, D. M., J. M. Montgomery, S. V. Newland, J. W. Priest, and P. J. Lammie. 2004. Detection of Cryptosporidium antibodies in sera and oral fluids using multiplex bead assay. J. Parasitol. 90:397-404.
51. Moss, D. M., S. N. Bennett, M. J. Arrowood, S. P. Wahlquist, and P. J. Lammie. 1998. Enzyme-linked immunoelectrotransfer blot analysis of a cryptosporidiosis outbreak on a United States Coast Guard cutter. Am. J. Trop. Med. Hyg. 58:110-118.
52. Muller, N., and S. Stager. 1999. Periodic appearance of a predominant variant antigen type during chronic Giardia lamblia infection in a mouse model. Int. J. Parasitol. 29:1917-1923.
53. Muller, N., S. Stager, and B. Gottstein. 1996. Serologic analysis of antigenic heterogeneity of Giardia lamblia variant surface proteins. Infect. Immun. 64:1385-1390.
54. Nash, T. E. 1997. Antigenic variation in Giardia lamblia and the host's immune response. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352:1369-1375.
55. Nash, T. E. 2002. Surface antigenic variation in Giardia lamblia. Mol. Microbiol. 45:585-590.
56. Nash, T. E., A. Aggarwal, R. D. Adam, J. T. Conrad, and J. W. Merritt, Jr. 1988. Antigenic variation in Giardia lamblia. J. Immunol. 141:636-641.
57. Nash, T. E., and A. Aggarwal. 1986. Cytotoxicity of monoclonal antibodies to a subset of Giardia isolates. J. Immunol. 136:2628-2632.
58. Nash, T. E., and M. R. Mowatt. 1992. Characterization of a Giardia lamblia variant-specific surface protein (VSP) gene from isolate GS/M and estimation of the VSP gene repertoire size. Mol. Biochem. Parasitol. 51:219-228.
59. Nash, T. E., D. A. Herrington, G. A. Losonsky, and M. M. Levine. 1987. Experimental infections with Giardia lamblia. J. Infect. Dis. 156:974-984.
60. Nash, T. E., D. A. Herrington, M. W. Levine, J. T. Conrad, and J. W. Merritt, Jr. 1990. Antigenic variation of Giardia lamblia in experimental human infections. J. Immunol. 144:4362-4369.
61. Nash, T. E., J. T. Conrad, and M. R. Mowatt. 1995. Giardia lamblia: identification and characterization of a variant-specific surface protein gene family. J. Eukaryot. Microbiol. 42:604-609.
62. Nash, T. E., S. M. Banks, D. Alling, J. W. Merritt, Jr., and J. T. Conrad. 1990. Frequency of variant antigens in Giardia lamblia. Exp. Parasitol. 71: 415-421.
63. Nash, T. E., T. McCutchan, D. Keister, J. B. Dame, J. D. Conrad, and F. D. Gillin. 1985. Restriction-endonuclease analysis of DNA from 15 Giardia isolates obtained from humans and animals. J. Infect. Dis. 152:64-73.
64. Newman, R. D., S. R. Moore, A. A. M. Lima, J. P. Nataro, R. L. Guerrant, and C. L. Sears. 2001. A longitudinal study of Giardia lamblia infection in north-east Brazilian children. Trop. Med. Int. Health 6:624-634.
65. Okhuysen, P. C., C. L. Chappell, J. H. Crabb, C. R. Sterling, and H. L. DuPont. 1999. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180:1275-1281.
66. Ong, C. S. L., D. L. Eisler, S. H. Goh, J. Tomblin, F. M. Awad-el-Kariem, C. B. Beard, L. Xiao, I. Sulaiman, A. Lal, M. Fyfe, A. King, W. R. Bowie, and J. L. Isaac-Renton. 1999. Molecular epidemiology of cryptosporidiosis outbreaks and transmission in British Columbia, Canada. Am. J. Trop. Med. Hyg. 61:63-69.
67. Palm, J. E. D., M. E.-L. Wieland, W. J. Griffiths, I. Ljungstrom, and S. G. Svard. 2003. Identification of immunoreactive proteins during acute human giardiasis. J. Infect. Dis. 187:1849-1859.
68. Papanastasiou, P., A. Hiltpold, C. Bommeli, and P. Kohler. 1996. The release of the variant surface protein of Giardia to its soluble isoform is mediated by the selective cleavage of the conserved carboxy-terminal domain. Biochemistry 35:10143-10148.
69. Papanastasiou, P., M. J. McConville, J. Ralton, and P. Kohler. 1997. The variant-specific surface glycoprotein of Giardia, VSP4A1, is a glycosylated and palmitoylated protein. Biochem. J. 322:49-56.
70. Priest, J. W., A. Li, M. D. Khan, M. J. Arrowood, P. J. Lammie, C. S. Ong, J. M. Roberts, and J. Isaac-Renton. 2001. Enzyme immunoassay detection of antigen-specific immunoglobulin G antibodies in longitudinal serum samples from patients with cryptosporidiosis. Clin. Diagn. Lab. Immunol. 8:415-423.
71. Priest, J. W., A. Mehlert, D. M. Moss, M. J. Arrowood, and M. A. J. Ferguson. 2006. Characterization of the glycosylphosphatidylinositol anchor of the immunodominant Cryptosporidium parvum 17-kDa antigen. Mol. Biochem. Parasitol. 149:108-112.
72. Priest, J. W., C. Bern, J. M. Roberts, J. P. Kwon, A. G. Lescano, W. Checkley, L. Cabrera, D. M. Moss, M. J. Arrowood, C. R. Sterling, R. H. Gilman, and P. J. Lammie. 2005. Changes in serum immunoglobulin G levels as a marker for Cryptosporidium sp. infection in Peruvian children. J. Clin. Microbiol. 43:5298-5300.
73. Priest, J. W., C. Bern, L. Xiao, J. M. Roberts, J. P. Kwon, A. G. Lescano, W. Checkley, L. Cabrera, D. M. Moss, M. J. Arrowood, C. R. Sterling, R. H. Gilman, and P. J. Lammie. 2006. Longitudinal analysis of Cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clin. Vaccine Immunol. 13:123-131.
74. Priest, J. W., J. P. Kwon, D. M. Moss, J. M. Roberts, M. J. Arrowood, M. S. Dworkin, D. D. Juranek, and P. J. Lammie. 1999. Detection by enzyme immunoassay of serum immunoglobulin G antibodies that recognize specific Cryptosporidium parvum antigen. J. Clin. Microbiol. 37:1385-1392.
75. Priest, J. W., J. P. Kwon, M. J. Arrowood, and P. J. Lammie. 2000. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol. Biochem. Parastiol. 106:261-271.
76. Priest, J. W., L.-T. Xie, M. J. Arrowood, and P. J. Lammie. 2001. The immunodominant 17-kDa antigen from Cryptosporidium parvum is glycosylphosphatidylinositol- anchored. Mol. Biochem. Parasitol. 113:117-126.
77. Prucca, C. G., I. Slavin, R. Quiroga, E. V. Elias, F. D. Rivero, A. Saura, P. G. Carranza, and H. D. Lujan. 2008. Antigenic variation in Giardia lamblia is regulated by RNA interference. Nature 456:750-754.
78. Prucca, C. G., and H. D. Lujan. 2009. Antigenic variation in Giardia lamblia. Cell. Microbiol. 11:1706-1715.
79. Riggs, M. W. 2002. Recent advances in cryptosporidiosis: the immune response. Microbes Infect. 4:1067-1080.
80. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
81. Savioli, L., H. Smith, and A. Thompson. 2006. Giardia and Cryptosporidium join the 'Neglected Diseases Initiative'. Trends Parasitol. 22:203-208.
82. Smith, H. V., S. M. Caccio, N. Cook, R. A. B. Nichols, and A. Tait. 2007. Cryptosporidium and Giardia as foodborne zoonoses. Vet. Parasitol. 149: 29-40.
83. Smith, P. D., F. D. Gillin, W. R. Brown, and T. E. Nash. 1981. IgG antibody to Giardia lamblia detected by enzyme-linked immunosorbent assay. Gastroenterology 80:1476-1480.
84. Soliman, M. M., R. Taghi-Kilani, A. F. A. Abou-Shady, A. A. El-Mageid, A. A. Handousa, M. M. Hegazi, and M. Belosevic. 1998. Comparison of serum antibody responses to Giardia lamblia of symptomatic and asymptomatic patients. Am. J. Trop. Med. Hyg. 58:232-239.
85. Stager, S., R. Felleisen, B. Gottstein, and N. Muller. 1997. Giardia lamblia variant surface protein H7 stimulates a heterogeneous repertoire of antibodies displaying differential cytological effects on the parasite. Mol. Biochem. Parasitol. 85:113-124.
86. Strong, W. B., J. Gut, and R. G. Nelson. 2000. Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton surface antigen products. Infect. Immun. 68:4117-4134.
87. Sturbaum, G. D., B. H. Jost, and C. R. Sterling. 2003. Nucleotide changes within three Cryptosporidium parvum surface protein encoding genes differentiate genotype I from genotype II isolates. Mol. Biochem. Parasitol. 128: 87-90.
88. Sullivan, P. B., G. Neale, A. M. Cevallos, and M. J. G. Farthing. 1991. Evaluation of specific serum anti-Giardia IgM antibody response in diagnosis of giardiasis in children. Trans. R. Soc. Trop. Med. Hyg. 85:748-749.
89. Thompson, R. C. A., R. M. Hopkins, and W. L. Homan. 2000. Nomenclature and genetic groupings of Giardia infecting mammals. Parasitol. Today 16: 210-213.
90. Tsang, V. C. W., and P. P. Wilkins. 1991. Optimum dissociating condition for immunoaffinity and preferential isolation of antibodies with high specific activity. J. Immunol. Methods 138:291-299.
91. Waterboer, T., P. Sehr, and M. Pawlita. 2006. Suppression of non-specific binding in serological Luminex assays. J. Immunol. Methods 309:200-204.
92. Weber, R., R. T. Bryan, H. S. Bishop, S. P. Wahlquist, J. J. Sullivan, and D. D. Juranek. 1991. Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J. Clin. Microbiol. 29:1323-1327.
93. Weiland, M. E.-L., J. E. D. Palm, W. J. Griffiths, J. M. McCaffery, and S. G. Svard. 2003. Characterization of alpha-1 giardin: an immunodominant Giardia lamblia annexin with glycosaminoglycan-binding activity. Int. J. Parasitol. 33:1341-1351.
94. Zweig, M. H., and G. Campbell. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:561-577.